D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith
{"title":"P2x3受体拮抗剂Gefapixant治疗难治性和不明原因慢性咳嗽的两项3期随机对照试验(cough1和cough2)的基本原理和设计","authors":"D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":160937,"journal":{"name":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","volume":"305 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough\",\"authors\":\"D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":160937,\"journal\":{\"name\":\"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS\",\"volume\":\"305 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough